WASHINGTON (AP) — The multi-decade search for a pill that boosts sexual desire in women has hit another roadblock, raising questions about the future of efforts to develop a female equivalent to Viagra.

Sprout Pharmaceuticals said Wednesday it has reached an impasse with the Food and Drug Administration over its drug, flibanserin. The daily pill is designed to increase libido in women by acting on brain chemicals linked to mood and appetite.

Recommended Stories

Study: Husbands need Viagra when wives earn more money

Safety advocates seek stronger warnings on Chantix

Drinking allowed: FDA rolls back alcohol restriction on female libido pill